The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment-Reference-Cited by-同舟云学术

The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment

Published:2016-07-11 Issue:7 Volume:74 Page:627-633
ISSN:1897-4279
Container-title:Kardiologia Polska
language:
Short-container-title:Kardiol Pol

Author:

Gil Robert J.,Bil Jacek,Pawłowski Tomasz,Yuldashev Nabijon,Kołakowski Leszek,Jańczak Jacek,Jabłoński Wojciech,Paliński Piotr

Publisher

Polskie Towarzystwo Kardiologiczne

Subject

Cardiology and Cardiovascular Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An investigation of PLLA hybrid stent design to overcome thick strut problems;International Journal of Solids and Structures;2024-10

2. Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results;Journal of Clinical Medicine;2023-08-15

3. Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?;The Anatolian Journal of Cardiology;2021-11-29

4. Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry;Journal of Clinical Medicine;2019-05-30

5. Hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in KUM ABSORB registry;Catheterization and Cardiovascular Interventions;2018-09-19